Filing Details
- Accession Number:
- 0000899243-17-027953
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-05 16:18:33
- Reporting Period:
- 2017-12-01
- Accepted Time:
- 2017-12-05 16:18:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1322505 | Albireo Pharma Inc. | ALBO | Pharmaceutical Preparations (2834) | 1231 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 901832 | Plc Astrazeneca | 1 Francis Crick Avenue Cambridge X0 CB2 OAA | No | No | Yes | No | |
| 928966 | Ab Astrazeneca | C/O Astrazeneca Plc 1 Francis Crick Avenue Cambridge X0 CB2 OAA | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value Per Share | Disposition | 2017-12-01 | 500,000 | $21.40 | 508,141 | No | 4 | S | Indirect | Held by AstraZeneca AB |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | Held by AstraZeneca AB |
Footnotes
- All of these securities are owned by AstraZeneca AB, which is a wholly-owned subsidiary of AstraZeneca PLC. AstraZeneca PLC may be deemed to indirectly beneficially own the shares held by AstraZeneca AB, but disclaims beneficial ownership except to the extent of its pecuniary interest therein, if any. The principal business address of AstraZeneca AB is SE-151, 85 Sodertalje, Sweden.
Billionaire Hedge Funds
